EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Nanobody-drug conjugates for targeting specific GPCR pairs

Xianglin Huang iD, Bryan L Roth iD

PLOS Biology · 2025

DOI: 10.1371/journal.pbio.3003483 ↗

Kurz gefasst

Kommentar in der Zeitschrift PLOS Biology, 2025. Verfasst von Xianglin Huang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Single-Domain Antibodies. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledSingle-Domain AntibodiesHumansLigandsClick ChemistrySignal TransductionBinding SitesAnimals

Substanzen

Receptors, G-Protein-CoupledSingle-Domain AntibodiesLigands

Autor:innen und Institutionen

  • Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

ORCID-Profile: Xianglin Huang, Bryan L Roth

Zitieren

APA

Huang, X., & Roth, B. L. (2025). Nanobody-drug conjugates for targeting specific GPCR pairs. PLOS Biology. https://doi.org/10.1371/journal.pbio.3003483

Vancouver

Huang X, Roth BL. Nanobody-drug conjugates for targeting specific GPCR pairs. PLOS Biology. 2025. doi:10.1371/journal.pbio.3003483

BibTeX
@article{Huang2025,
  author = {Huang, Xianglin and Roth, Bryan L},
  title = {Nanobody-drug conjugates for targeting specific GPCR pairs},
  journal = {PLOS Biology},
  year = {2025},
  doi = {10.1371/journal.pbio.3003483}
}
Kostenlos starten →